November 13, 2015 9:40 AM | 2 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Analysts at Bernstein initiated coverage on
SolarCity Corp (NASDAQ: SCTY) with a Market Perform rating. The target price for SolarCity is set to $30. SolarCity shares closed at $25.07 on Thursday. Roth Capital initiated coverage on
Outerwall Inc (NASDAQ: OUTR) with a Buy rating. The target price for Outerwall is set to $80. Outerwall shares closed at $61.92 on Thursday.JP Morgan initiated coverage on
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) with a Overweight rating. The target price for Momenta Pharmaceuticals is set to $26. Momenta Pharmaceuticals shares closed at $17.76 on Thursday.Citigroup initiated coverage of
Jacobs Engineering Group Inc (NYSE: JEC) with a Buy rating. Jacobs Engineering shares closed at $40.43 on Thursday.Analysts at William Blair initiated coverage on
Harman International Industries Inc./DE/ (NYSE: HAR) with a Outperform rating. Harman International shares closed at $99.42 on Thursday.Baird initiated coverage on
First Data Corp (NYSE: FDC) with a Neutral rating. The target price for First Data is set to $20. First Data shares closed at $17.67 on Thursday. Analysts at Citigroup initiated coverage of
McDermott International (NYSE: MDR) with a Neutral rating. McDermott shares closed at $5.64 on Thursday.Analysts at Baird initiated initiated coverage on
Himax Technologies, Inc. (ADR) (NASDAQ: HIMX) with a Outperform rating. The target price for Himax Technologies is set to $9. Himax Technologies shares closed at $6.15 on Thursday. Analysts at Roth Capital initiated coverage on
Glu Mobile Inc. (NASDAQ: GLUU) with a Buy rating. The target price for Glu Mobile is set to $5. Glu Mobile shares closed at $3.15 on Thursday.Analysts at Cowen & Company initiated coverage on
Tobira Therapeutics Inc (NASDAQ: TBRA) with a Outperform rating. The target price for Tobira Therapeutics is set to $21. Tobira Therapeutics shares closed at $9.70 on Thursday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.